Inventor · disambiguated record
Richard Angell
Also filed as: ANGELL RICHARD · ANGELL RICHARD M · ANGELL RICHARD MARTYN
13 granted patents·9 pending applications·171 citations·filing 1998–2024
92Inventor score
Files withGLAXO GROUP LTD10UCL BUSINESS LTD4SMITHKLINE BEECHAM CORP3ASTRAZENECA AB1GLAXOSMITHKLINE LLC1
Top patents by PatentIndex Score
22 records- 0190US7309800B2Biphenylcarboxylic amide derivatives as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Dec 18, 2007·17 cites·13 claims
- 0287US7151118B2Biphenylcarboxylic amide derivatives as p38-kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Dec 19, 2006·27 cites·15 claims
- 0386US7166623B22′-Methyl-5′-(1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Jan 23, 2007·22 cites·14 claims
- 0482US7208629B25′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Apr 24, 2007·20 cites·17 claims
- 0581US7384963B22′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinaseGLAXO GROUP LTD·Filed 2002·Granted Jun 10, 2008·15 cites·11 claims
- 0680US7183297B2Biphenyl-derivatives as p38-kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Feb 27, 2007·14 cites·21 claims
- 0779US7432289B25-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Oct 7, 2008·14 cites·13 claims
- 0878US7396843B25′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Jul 8, 2008·12 cites·20 claims
- 0977US2025129065A1Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 1076US7425555B2Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 16, 2008·13 cites·16 claims
- 1175US8008303B2Biphenyl derivatives and their use in treating hepatitis CASTRAZENECA AB·Filed 2006·Granted Aug 30, 2011·6 cites·20 claims
- 1275US2023212166A1Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1371US7642276B2Fused heteroaryl derivatives for use as P38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 5, 2010·9 cites·16 claims
- 1467US11560380B2Substituted naphthalene diimides and their useUCL BUSINESS LTD·Filed 2020·Granted Jan 24, 2023·0 cites·18 claims
- 1567US9809575B2Pharmaceutical compoundsREVIRAL LTD·Filed 2012·Granted Nov 7, 2017·2 cites·10 claims
- 1658US2025263404A1Aminopyridines as activators of pi3 kinaseUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1753US2007142476A1Biphenyl-Derivatives as p38 Kinase InhibitorsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 1853US2007112046A12'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 1951US2011053934A1Compounds and methods of treatmentGLAXOSMITHKLINE LLC·Filed 2010·Application pending·0 cites
- 2044US2005070515A1CompoundsSMITHKLINE BEECHAM CORP·Filed 2003·Application pending·0 cites
- 2142US2005065195A1Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 2223US2002019378A1CompoundsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Angell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →